1S. S. Asghar,W. Westerhof,P. K. Das,F. Ch. Jansen,R. H. Cormane. Treatment of vasculitis with chlorpromazine and dapsone[J] 1985,Archives of Dermatological Research(6):504～506
4Reinehr T, Btirk G, Andler W. Does steroid treatment of abdominal- pain prevent renal involvement in Henoch-Schonleinpurpura? [ J]. J Pediatr Gastroenterol Nutr, 2000, 31: 323- 324.
5Ronkainen :1, Koskimies O, Ala- Houhala M, et al. Early prednisone- therapy in Henoch - Schonlein purpura: a randomized, double-blind, placebo-controlled trial[ J]. J Pediatr, 2006, 149:241 - 247.
6Gianviti A, Trompeter RS, Barratt TM, et al. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomeru- lonephritis and vasculitis[ J]. Arch Dis Child, 1996,75 : 186 - 190.
7Kawasaki Y, Suzuki J, Mural M, et al, Plasmapheresis therapy for rapid- ly progressive Henoch-Schonlein nephritis [ J ]. Pediatr Nephrol,2004, 19:920 - 923.
8Sano H, Izumida M, Shimizu H, et al. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura[ J]. Eur J Pe- diatr,2002,161 : 196 - 201.
9Fukui H,Kamitsuji H,Nagao T,et al. Clinical evaluation of a pasteur- ized factor XIII concentrate administration in Henoch-Sehonlein purpu- ra. Japanese Pediatric group [ J ]. Thromb Res, 1989,56:667 - 675.
